SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-23-000009
Filing Date
2023-08-10
Accepted
2023-08-10 16:32:55
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20230630.htm   iXBRL 10-Q 721433
2 EX-31.1 ex-311q22023.htm EX-31.1 8998
3 EX-32.1 ex-321q22023.htm EX-32.1 4299
  Complete submission text file 0001113148-23-000009.txt   3911419

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20230630.xsd EX-101.SCH 41322
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20230630_cal.xml EX-101.CAL 42453
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20230630_def.xml EX-101.DEF 142791
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20230630_lab.xml EX-101.LAB 433185
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20230630_pre.xml EX-101.PRE 263063
55 EXTRACTED XBRL INSTANCE DOCUMENT infi-20230630_htm.xml XML 367670
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 231160103
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences